RNA Canada ARN would like to invite you to a roundtable discussion on: “Regulation and evaluation of RNA-based technologies” (Thursday October 3rd 2024, during lunch 13h05-14h45). RNA has now shown a fantastic potential for many health problems, but challenges remain beyond finding and devising drugs. This roundtable will approach the subject of what happens after initial drug discovery and confirmation before drugs and technologies become accessible to patients. Among other subjects, emerging trends and challenges of RNA technology regulation will be discussed as well as considerations regarding precision medicine.
The panel will be moderated by Dan Edgcumbe, Roche Canada. Panelists will be:
-
Mélanie Caron, Director, Direction of drug and technologies evaluation, Institut national d’excellence en santé et en services sociaux (INESSS)
-
Omar Tounekti, Manager Cell, Gene Therapies and Radiopharmaceuticals Division, Health Canada
-
Gregory Troiano, Head of cGMP Strategic Supply & Operations, Sanofi
-
Leslie Madden, Sr Director, Regulatory Science, Moderna
Hope to see you there!
